Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VR506 inhalation powder in a new dry powder inhaler for adolescents and adults with asthma
2011-001772-19Phase 2Completed
- Sponsor
- Vectura
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing VR506 inhalation powder with Placebo inhalation powder (2 arms). Primary endpoint: Change from baseline in morning pre-dose FEV1 at end of study. Started Sep 2011; status: completed.
02
Drugs
VR506
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-001772-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001772-19.